Apart from BMI, the prevalence of obesity, and the serum concentrations of total cholesterol and HDL cholesterol, there were no significant differences in the analyzed variables in diabetic patients with CAD in regard to genetically predicted AMPD1 activity (full enzyme activity vs. intermediate enzyme activity vs. null enzyme activity). Here, AMPD1 is linked to obesity due to melanocortin 4 receptor deficiency.